These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35960189)

  • 21. Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer's disease.
    Kim D; Basile AO; Bang L; Horgusluoglu E; Lee S; Ritchie MD; Saykin AJ; Nho K
    BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):61. PubMed ID: 28539126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
    Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
    J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penalized estimation of semiparametric transformation models with interval-censored data and application to Alzheimer's disease.
    Li S; Wu Q; Sun J
    Stat Methods Med Res; 2020 Aug; 29(8):2151-2166. PubMed ID: 31718478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint model for survival and multivariate sparse functional data with application to a study of Alzheimer's Disease.
    Li C; Xiao L; Luo S
    Biometrics; 2022 Jun; 78(2):435-447. PubMed ID: 33501651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNN-based longitudinal analysis for diagnosis of Alzheimer's disease.
    Cui R; Liu M;
    Comput Med Imaging Graph; 2019 Apr; 73():1-10. PubMed ID: 30763637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor-augmented transformation models for interval-censored failure time data.
    Li H; Li S; Sun L; Song X
    Biometrics; 2024 Jul; 80(3):. PubMed ID: 39177025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer's disease across imaging databases.
    Casanova R; Barnard RT; Gaussoin SA; Saldana S; Hayden KM; Manson JE; Wallace RB; Rapp SR; Resnick SM; Espeland MA; Chen JC;
    Neuroimage; 2018 Dec; 183():401-411. PubMed ID: 30130645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2012 Feb; 8(1 Suppl):S1-68. PubMed ID: 22047634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Random forest feature selection, fusion and ensemble strategy: Combining multiple morphological MRI measures to discriminate among healhy elderly, MCI, cMCI and alzheimer's disease patients: From the alzheimer's disease neuroimaging initiative (ADNI) database.
    Dimitriadis SI; Liparas D; Tsolaki MN;
    J Neurosci Methods; 2018 May; 302():14-23. PubMed ID: 29269320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ensemble of convolutional neural networks and multilayer perceptron for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Li M; Jiang Y; Li X; Yin S; Luo H
    Med Phys; 2023 Jan; 50(1):209-225. PubMed ID: 36121183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroimaging modality fusion in Alzheimer's classification using convolutional neural networks.
    Punjabi A; Martersteck A; Wang Y; Parrish TB; Katsaggelos AK;
    PLoS One; 2019; 14(12):e0225759. PubMed ID: 31805160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatio-temporal convolution for classification of alzheimer disease and mild cognitive impairment.
    Turhan G; Küçük H; Isik EO
    Comput Methods Programs Biomed; 2022 Jun; 221():106825. PubMed ID: 35636355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal score prediction for Alzheimer's disease based on ensemble correntropy and spatial-temporal constraint.
    Lei B; Hou W; Zou W; Li X; Zhang C; Wang T
    Brain Imaging Behav; 2019 Feb; 13(1):126-137. PubMed ID: 29582337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease progression modelling of Alzheimer's disease using probabilistic principal components analysis.
    Saint-Jalmes M; Fedyashov V; Beck D; Baldwin T; Faux NG; Bourgeat P; Fripp J; Masters CL; Goudey B;
    Neuroimage; 2023 Sep; 278():120279. PubMed ID: 37454702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.
    Wang HF; Tan L; Cao L; Zhu XC; Jiang T; Tan MS; Liu Y; Wang C; Tsai RM; Jia JP; Yu JT;
    J Alzheimers Dis; 2016; 51(1):227-36. PubMed ID: 26836176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of back propagation neural networks and 18F-Florbetapir PET for early detection of Alzheimer's disease using Alzheimer's Disease Neuroimaging Initiative database.
    Ozsahin I; Sekeroglu B; Mok GSP
    PLoS One; 2019; 14(12):e0226577. PubMed ID: 31877173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analyzing the effect of APOE on Alzheimer's disease progression using an event-based model for stratified populations.
    Venkatraghavan V; Klein S; Fani L; Ham LS; Vrooman H; Ikram MK; Niessen WJ; Bron EE;
    Neuroimage; 2021 Feb; 227():117646. PubMed ID: 33338617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GWAS-Linked Loci and Neuroimaging Measures in Alzheimer's Disease.
    Li JQ; Wang HF; Zhu XC; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT;
    Mol Neurobiol; 2017 Jan; 54(1):146-153. PubMed ID: 26732597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep learning-based polygenic risk analysis for Alzheimer's disease prediction.
    Zhou X; Chen Y; Ip FCF; Jiang Y; Cao H; Lv G; Zhong H; Chen J; Ye T; Chen Y; Zhang Y; Ma S; Lo RMN; Tong EPS; ; Mok VCT; Kwok TCY; Guo Q; Mok KY; Shoai M; Hardy J; Chen L; Fu AKY; Ip NY
    Commun Med (Lond); 2023 Apr; 3(1):49. PubMed ID: 37024668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rare variants in the splicing regulatory elements of EXOC3L4 are associated with brain glucose metabolism in Alzheimer's disease.
    Miller JE; Shivakumar MK; Lee Y; Han S; Horgousluoglu E; Risacher SL; Saykin AJ; Nho K; Kim D;
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):76. PubMed ID: 30255815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.